Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs BC Evans, CE Nelson, SY Shann, KR Beavers, AJ Kim, H Li, HM Nelson, ... JoVE (Journal of Visualized Experiments), e50166, 2013 | 480 | 2013 |
Scaling and systems biology for integrating multiple organs-on-a-chip JP Wikswo, EL Curtis, ZE Eagleton, BC Evans, A Kole, LH Hofmeister, ... Lab on a Chip 13 (18), 3496-3511, 2013 | 313 | 2013 |
Endosomolytic nano-polyplex platform technology for cytosolic peptide delivery to inhibit pathological vasoconstriction BC Evans, KM Hocking, KV Kilchrist, ES Wise, CM Brophy, CL Duvall ACS nano 9 (6), 5893-5907, 2015 | 54 | 2015 |
MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia BC Evans, KM Hocking, MJ Osgood, I Voskresensky, J Dmowska, ... Science translational medicine 7 (291), 291ra95-291ra95, 2015 | 52 | 2015 |
Delivery of intracellular-acting biologics in pro-apoptotic therapies H Li, C E Nelson, B C Evans, C L Duvall Current pharmaceutical design 17 (3), 293-319, 2011 | 51 | 2011 |
Hydrolytic charge‐reversal of PEG ylated polyplexes enhances intracellular un‐packaging and activity of si RNA TA Werfel, C Swain, CE Nelson, KV Kilchrist, BC Evans, M Miteva, ... Journal of Biomedical Materials Research Part A 104 (4), 917-927, 2016 | 14 | 2016 |
Polyplexes C Duvall, BC Evans, C Brophy, K Hocking US Patent 10,835,549, 2020 | 2 | 2020 |
Peptide and SiRNA Modulation of HSP20 Influences Vasoreactivity KM Hocking, B Evans, P Komalavilas, CL Duvall, CM Brophy Arteriosclerosis, Thrombosis, and Vascular Biology 34 (suppl_1), A520-A520, 2014 | | 2014 |
Enhanced intracellular peptide delivery with pH-responsive, endosomolytic nano-polyplexes to modulate vascular smooth muscle cell behavior BC Evans | | 2013 |